About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 495 record(s)
Req # A-2022-001575
Written policies and procedures of Health Canada Exemptions section for dealing with Exemption Applications under subsection 56(1) exemption as it pertains to religious exemptions.Organization: Health Canada
June 2023
Req # A-2022-001587
All submissions made by Sunshine Labs made to Health Canada for an amendment to include cocaine under a Controlled Substances Dealer’s License. Restrict Search to the Office of Controlled Substances. Date range for Records Search: 09/01/2022 to 12/…Organization: Health Canada
June 2023
Req # A-2022-001662
All work descriptions for IS-03, IS-04 and IS-05 level positions where the main responsibilities/duties of the position involve the web and/or social media.Organization: Health Canada
June 2023
Req # A-2023-000024
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-03-24 for the medicinal ingredient Levothyroxine…Organization: Health Canada
June 2023
Req # A-2023-000048
The initial cover letter indicating the brand name of the reference drug product and the dosage form of any generic submission (ANDS) having the medicinal ingredient Tolvaptan. The Screening Acceptance Letter from Health Canada to the generic drug…Organization: Health Canada
June 2023
Req # A-2023-000096
Any correspondence between Communications and Public Affairs Branch's (CPAB) Social Media team and Facebook, Twitter, or Google between February 1, 2023 and February 28, 2023. Executive Correspondence with Facebook, Twitter, or Google between…Organization: Health Canada
June 2023
Req # A-2023-000150
Any communications with social media companies referencing Rebel News/Rebel Media/The Rebel, since January 1, 2020.Organization: Health Canada
June 2023
Req # A-2023-000158
Information relating to this Company, the relevant information of which is summarized here: Société Boucherie B. Poirier Inc. NEQ: 1166185729. Address of building: 4 SAINT-JOSEPH, SAINT-LOUIS-DEGONZAGUE, QC J0S1T0. Cadastre: 5125270, 5782981.Organization: Health Canada
June 2023
Req # A-2023-000172
Year-by-year data on serious Adverse Drug Reaction (ADR) reporting by hospitals from January 1, 2018 to December 31, 2022 broken down by hospital.Organization: Health Canada
June 2023
Req # A-2023-000176
The Interprovincial Billing Rates for all provinces and for all Outpatient and Inpatient Services including daily ward and Intensive Care Unit (ICU) rates for April onward. Interprovincial Billing Rates Effective: a. April 1st, 2022; and b. April…Organization: Health Canada
June 2023